LOADING…
SPECIFICATIONS
01 / Metabolic / MZD-10
GLP-1/glucagon dual receptor agonist. 10 mg lyophilized vial.
DOSE
QUANTITY
BUNDLE & SAVE
SHIPS
TODAY · 2-5 BIZ DAYS
PAY WITH
USDC · SOLANA
REFERENCE
COMPOUND DATA AND PEER-REVIEWED CITATIONS FOR MAZDUTIDE. FOR RESEARCH USE ONLY.
COMPOUND INFORMATION · TECHNICAL SPECIFICATIONS
MOLECULAR PROFILE
SYNONYMS
STORAGE REQUIREMENTS
LYOPHILIZED (POWDER)
-20°C · up to 2 years
RECONSTITUTED
2-8°C · up to 30 days
SOURCES & REFERENCES · PEER-REVIEWED RESEARCH · 8 CITATIONS FOR MAZDUTIDE
THE NEW ENGLAND JOURNAL OF MEDICINE
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.
2025 · PMID 40421736
Ji L, Jiang H et al.
VIEW SOURCE →
PHARMACOLOGICAL REVIEWS
Emerging pharmacotherapies for obesity: A systematic review.
2025 · PMID 39952695
Kokkorakis M, Chakhtoura M et al.
VIEW SOURCE →
DIABETES CARE
IMPORTANT RESEARCH NOTICE
NOT FOR HUMAN CONSUMPTION. THIS PRODUCT IS SOLD EXCLUSIVELY FOR RESEARCH AND EDUCATIONAL PURPOSES. IT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
ALL CITATIONS ON THIS PAGE ARE SOURCED FROM PUBMED AND PUBCHEM PUBLIC DATABASES. THEY ARE PROVIDED FOR EDUCATIONAL REFERENCE ONLY AND SHOULD NOT BE INTERPRETED AS MEDICAL ADVICE OR PRODUCT CLAIMS.
BY PURCHASING THIS PRODUCT, YOU CONFIRM THAT YOU ARE A QUALIFIED RESEARCHER AND WILL USE IT IN ACCORDANCE WITH ALL APPLICABLE LAWS.
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
2024 · PMID 37943529
Zhang B, Cheng Z et al.
VIEW SOURCE →